Table 5. Number of Infections, Location, Main Organisms, and Distribution of Treatment for Infected Patients.
| Frequency (n) | Percent | |
|---|---|---|
| Number of infections | ||
|
| ||
| 1 | 107 | 77.5 |
| 2 | 25 | 18.1 |
| 3 | 5 | 3.6 |
| 5 | 1 | 0.7 |
|
| ||
| Location of infection | ||
|
| ||
| Pleural effusion | 1 | 0.7 |
| Sputum | 35 | 25.4 |
| Tissue | 1 | 0.7 |
| Unlisted* | 28 | 20.3 |
| Urine | 20 | 14.5 |
| Blood | 56 | 40.6 |
| Wound | 6 | 4.3 |
|
| ||
| Organisms of infection | ||
|
| ||
| Culture contaminants | 2 | 1.4 |
| E. coli | 10 | 7.2 |
| Other | 50 | 36.2 |
| P. aeruginosa | 7 | 5.1 |
| Staph. aureus | 13 | 9.4 |
| Staph. epidermis | 5 | 3.6 |
| Staph. species | 8 | 5.8 |
| Strep. pneumoniae | 3 | 2.2 |
| Strep. species | 8 | 5.8 |
| Unlisted† | 28 | 20.3 |
|
| ||
| Distribution of treatment for infected patients | ||
|
| ||
| Placebo | 72 | 52.2 |
| Pexelizumab | 66 | 47.8 |
*
“Unlisted” is a patient who is infected but with no culture data.
†
“Unlisted” is a patient who is infected but with no organism data.